Health Economic Modeling in Personalized Medicine
A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models
Timed Automata vs. Discrete Event Simulation
Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer
Parameter Uncertainty in Microsimulation Models
Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models
State-Transition Modeling vs. Discrete Event Simulationimulation
Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients
Competing Risks in Discrete Event Simulation Models based on Uncensored Data
Comparing strategies for modeling competing risks in discrete event simulations: a simulation study and illustration in colorectal cancer
Competing Risks in Discrete Event Simulation Models based on Censored Data
Comparing modeling approaches for discrete event simulations of competing events based on censored individual patient data: a simulation study and illustration in colorectal cancer
Using Metamodels to reduce Computational Burden of Advanced Health Economic Analyses
A scoping review of metamodeling applications and opportunities for advanced health economic analysesanalyses
Real World Data based Simulation Study on Treatment Sequencing in Metastatic Colorectal Cancer Treatment
Simulating progression-free survival and overall survival for first-line doublet chemotherapy with or without bevacizumab in metastatic colorectal cancer patients based on real world registry data
